Heart Failure

Key Points

• Heart failure (HF) is decreased cardiac output from ineffective pumping, often causing dyspnea, fatigue, edema, and congestion.
• Common causes include coronary artery disease, myocardial infarction, hypertension, valvular disease, and cardiomyopathy.
• NYHA functional class (I-IV) guides expected baseline findings, progression risk, and care intensity.
• Acute decompensated heart failure (ADHF) presents with sudden worsening and requires rapid escalation.
• Peripartum cardiomyopathy is a pregnancy-associated cause of systolic heart failure that requires maternal-fetal safety adaptations.
• Core management combines medication therapy, sodium and fluid strategies, symptom tracking, and coordinated follow-up.
• In infants and children, congenital heart defects are a major HF driver and often present as feeding intolerance, diaphoresis, growth delay, and congestion signs.

Pathophysiology

HF develops when myocardial pump function cannot meet tissue oxygenation and perfusion demands. Reduced forward flow and compensatory fluid-retention pathways produce fatigue, pulmonary congestion, and peripheral edema. As disease progresses, clients move along a continuum from asymptomatic risk to end-stage disease.

Etiologies include ischemic injury from coronary-artery-disease and MI, pressure overload from chronic hypertension-assessment-and-management, structural valve dysfunction, and inherited or acquired cardiomyopathy. These mechanisms impair ventricular filling and/or ejection and reduce effective perfusion reserve.

In late pregnancy and early postpartum periods, peripartum-cardiomyopathy can present with new systolic dysfunction and signs that may overlap with expected pregnancy discomforts. This overlap can delay diagnosis unless dyspnea, orthopnea, pulmonary congestion, and hemodynamic trends are assessed carefully.

Compensatory stretch can briefly increase stroke volume (Frank-Starling response), but chronic pressure and volume overload eventually become maladaptive. Over time, ventricles may hypertrophy or dilate with reduced recoil and weaker contractility, driving persistent HF symptom burden.

In pediatric populations, congenital structural defects can produce early pressure or volume overload that progresses to pulmonary congestion, systemic venous congestion, and reduced cardiac-output reserve. Clinical decline may appear first during feeding and crying because energy demand rises quickly in infants.

Classification

• Left-sided HF: Predominant pulmonary congestion pattern (dyspnea, orthopnea, crackles, reduced ejection fraction trends).
• Right-sided HF: Predominant systemic venous congestion pattern (peripheral edema, ascites, hepatomegaly, JVD).
• HF by ejection fraction context: Preserved EF is commonly above 50%; reduced EF is commonly at or below about 40% when HF manifestations are present.
• NYHA Class I-IV: Functional status classification by symptom limitation from no limitation to symptoms at rest.
• Acute decompensated HF (ADHF): Sudden or gradual worsening that requires urgent outpatient escalation or hospitalization.

Nursing Assessment

NCLEX Focus

Questions prioritize distinction between expected baseline findings and acute decompensation requiring immediate provider notification.

• Assess baseline versus current status for edema burden, lung sounds, mental status, and kidney function.
• Assess left-sided and right-sided symptom patterns, including orthopnea/PND, edema distribution, ascites, and JVD.
• Assess NYHA functional class to contextualize expected tolerance and detect meaningful decline.
• Assess for ADHF cues: worsening dyspnea, increased edema, new/worse crackles, confusion, and oliguria.
• Assess rapid weight-gain trend as a decompensation cue (for example more than about 2-3 lb in 24 hours).
• In pediatric congenital-HF contexts, assess feeding fatigue, diaphoresis during feeds/crying, poor growth, diminished peripheral pulses, hepatomegaly/abdominal distension, edema, and extra S3 gallop pattern.
• Escalate pallor, lethargy, bradycardia, apnea, or minimal spontaneous movement as impending cardiopulmonary collapse findings.
• Trend diagnostics used in HF workup and monitoring: BNP elevation context, chest X-ray pulmonary congestion, echocardiography ejection fraction (normal roughly 50-70%), and ECG rhythm findings.
• Interpret BNP trend with volume status because ventricular stretch from hypervolemia generally raises BNP and worsening congestion risk.
• Use EF context with ventricular-volume trends when available (SV = EDV - ESV, EF = SV/EDV) to interpret contractile performance over time.

Nursing Interventions

• Implement ordered therapies to support perfusion and gas exchange, including oxygen and IV diuretic pathways during acute worsening.
• Administer and monitor HF medication classes safely and watch for adverse effects, especially electrolyte imbalance from diuretic therapy.
• Teach symptom self-management and urgent reporting thresholds to reduce preventable ADHF admissions.
• Reinforce low-sodium dietary strategy (commonly less than 2-3 g/day), daily weights, blood-pressure logging, and follow-up adherence.
• Teach fluid-limiting plans when prescribed (often less than about 1.5-2 L/day in advanced HF or pulmonary edema contexts).
• Perform/assist daily or weekly weights as ordered, monitor intake/output, and apply compression stockings if prescribed.
• Escalate immediately for sudden chest pain, severe shortness of breath, or new white/pink foamy sputum.
• Encourage activity-rest balance, elevated head-of-bed/sleep positioning for orthopnea, smoking cessation, and participation in cardiac-rehabilitation-across-care-transitions.
• Support psychosocial coping and refer to mental-health and support-group resources when disease burden affects adherence and quality of life.
• In pediatric congenital-HF pathways, prepare for class-based medication plans (loop/thiazide diuretics, ACE inhibitor therapy, aldosterone antagonist, beta-blocker, inotrope, antiarrhythmic) with close rhythm and electrolyte surveillance.
• For pediatric digoxin pathways, count apical pulse for one full minute before dosing, hold and notify provider when infant apical heart rate is under 100 bpm (or below ordered age-specific parameters), and monitor for nausea, vomiting, bradycardia, or dysrhythmia toxicity cues.
• Track potassium and magnesium closely in children receiving digoxin plus diuretic therapy because electrolyte depletion increases toxicity risk.
• Coordinate frequent follow-up and escalation when congenital-defect correction or transplant-level evaluation is needed for end-stage deterioration.

ADHF Escalation Risk

Worsening dyspnea, edema progression, confusion, and falling urine output can indicate acute decompensation requiring urgent escalation.

Pharmacology

Drug Class	Examples	Key Nursing Considerations
Diuretic therapy	class-based HF use	Reduces congestion; monitor weight, urine output, potassium, and other electrolytes.
ACE inhibitor and ARB therapy	class-based HF use	Lowers systemic resistance and supports cardiac-output efficiency; monitor blood-pressure response.
Beta-blocker therapy	class-based HF use	Slows rate and may improve ventricular filling; monitor for intolerance and worsening status.
Aldosterone-antagonist therapy	class-based HF use	Supports fluid reduction; monitor electrolyte and kidney-function trends.
Inotrope therapy	digoxin and class-based acute/advanced use	Supports contractility in selected cases; requires close hemodynamic monitoring.

Clinical Judgment Application

Clinical Scenario

A patient with chronic HF baseline NYHA Class II reports 3-lb overnight weight gain, worsening dyspnea, and new ankle edema with diminished urine output.

• Recognize Cues: Rapid weight increase, respiratory worsening, edema progression, and oliguria indicate fluid-retention acceleration.
• Analyze Cues: Findings suggest transition from chronic baseline toward ADHF.
• Prioritize Hypotheses: Immediate priority is preventing respiratory and perfusion deterioration.
• Generate Solutions: Escalate promptly, intensify monitoring, and implement ordered oxygen/diuretic interventions.
• Take Action: Communicate trend data and reassessment findings to the provider without delay.
• Evaluate Outcomes: Dyspnea, oxygenation, edema, and urine output trends improve after treatment adjustment.

Related Concepts

• coronary-artery-disease - Ischemic myocardial injury is a common HF cause and progression driver.
• cardiovascular-system - Core cardiovascular physiology explains forward-flow failure and congestion patterns.
• cardiovascular-and-peripheral-vascular-nursing-assessment - Structured exam findings support early decompensation recognition.
• fluid-volume-overload-hypervolemia - Fluid-retention pathways overlap with edema and pulmonary-congestion management.
• congenital-heart-defects-acyanotic-and-cyanotic-patterns - Pediatric structural lesions are common upstream causes of infant HF.
• pulmonary-hypertension-in-congenital-heart-disease-and-pphn - Pulmonary vascular pressure overload can coexist with and worsen HF trajectories.
• digoxin - High-alert inotrope pathway in selected pediatric heart-failure plans.
• peripartum-cardiomyopathy - Pregnancy-associated systolic dysfunction can present as acute or progressive HF.
• readmission-reduction-programs-hrrp-and-value-based-purchasing - Discharge and follow-up reliability strongly affect 30-day HF outcomes.

Self-Check

1. Which findings distinguish expected chronic HF from acute decompensated HF?
2. How does NYHA classification change nursing assessment expectations and escalation thresholds?
3. Which home-monitoring cues should trigger same-day provider contact in HF self-management?